|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$81,761.19 |
2.36% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$80,732.51 |
2.33% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$79,067.03 |
2.28% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$78,637.21 |
2.27% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$78,068.48 |
2.25% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$77,780.94 |
2.24% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$77,514.57 |
2.23% |
| Steris Plc |
STE |
G8473T100 |
298 |
$76,568.12 |
2.21% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$76,808.79 |
2.21% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$75,992.08 |
2.19% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$75,360.04 |
2.17% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$75,243.63 |
2.17% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$75,181.68 |
2.17% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$74,907.00 |
2.16% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$74,317.17 |
2.14% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$73,817.10 |
2.13% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$73,646.59 |
2.12% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$73,081.93 |
2.11% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$73,048.74 |
2.11% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$72,253.48 |
2.08% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$72,290.75 |
2.08% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$71,110.19 |
2.05% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$71,164.71 |
2.05% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$70,947.42 |
2.04% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$70,743.01 |
2.04% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$70,860.13 |
2.04% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$70,619.46 |
2.04% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$69,998.11 |
2.02% |
| Waters Corporation |
WAT |
941848103 |
147 |
$70,074.90 |
2.02% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$69,379.07 |
2.00% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$69,544.56 |
2.00% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$68,419.92 |
1.97% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$68,492.45 |
1.97% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$67,954.25 |
1.96% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$67,563.75 |
1.95% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$67,779.33 |
1.95% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$66,698.80 |
1.92% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$65,897.94 |
1.90% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$65,449.09 |
1.89% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$65,535.72 |
1.89% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$64,807.58 |
1.87% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$64,811.86 |
1.87% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,370.00 |
1.86% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$64,359.88 |
1.85% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$61,613.20 |
1.78% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$60,623.45 |
1.75% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$59,588.96 |
1.72% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$57,800.57 |
1.67% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,564.74 |
1.28% |
| US Dollar |
$USD |
|
23,124 |
$23,123.50 |
0.67% |
| Japanese Yen |
$JPY |
|
42,336 |
$268.07 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
| Pound Sterling |
$GBP |
|
-410 |
($550.41) |
-0.02% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|